NYSEARCA:PBE

Invesco Biotechnology & Genome ETF (PBE) Price, Holdings, & News

Invesco Biotechnology & Genome ETF logo
$95.95 +0.26 (+0.27%)
As of 02:18 PM Eastern
This is a fair market value price provided by Massive. Learn more.

About Invesco Biotechnology & Genome ETF (NYSEARCA:PBE)

Advanced

Key Stats

Today's Range
$95.33
▼
$96.32
50-Day Range
$92.91
▼
$104.67
52-Week Range
$75.50
▼
$104.69
Volume
2,432 shs
Average Volume
14,480 shs
Market Capitalization
$426.02 million
Assets Under Management
$425.10 million
Dividend Yield
1.39%
Net Expense Ratio
0.58%
Aggregate Rating
Moderate Buy

ETF Overview

PowerShares Dynamic Biotechnology & Genome Portfolio (the Fund) is based on the Dynamic Biotechnology & Genome Intellidex Index (the Index). The Fund seeks investment results that correspond generally to the price and yield of the Index. The Index consists of stocks of 30 the United States biotechnology and genome companies. The Fund will normally invest at least 90% of its total assets in common stocks that consists of the Index. The Index is designed to provide capital appreciation by evaluating companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. Invesco PowerShares Capital Management LLC acts as the Fund's investment adviser.

Invesco Biotechnology & Genome ETF Expenses

TypePBEHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.50%0.55%0.57%0.50%0.53%
Other Expenses0.08%0.52%0.53%0.60%0.54%
Total Expense0.58%0.76%0.75%0.75%0.73%
Fee Waiver0.00%-0.85%-0.67%-0.76%-0.67%
Net Expense0.58%0.58%0.63%0.57%0.60%
Receive PBE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Invesco Biotechnology & Genome ETF and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PBE ETF News Headlines

Why I'm selling my Snapback Indicator for just $7
For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indicator for a single $7 payment. Others previously paid $500. The indicator flashes a Crash Alert as a cue to exit or go short, and a Bull Run Alert as a cue to buy or go long. No strings attached, and Wood says there is an unusual reason behind the steep discount.tc pixel
(PBE) Invesco Biotechnology & Genome ETF
See More Headlines

PBE ETF - Frequently Asked Questions

Invesco Biotechnology & Genome ETF's stock was trading at $82.15 at the start of the year. Since then, PBE shares have increased by 16.1% and is now trading at $95.3440.

Top institutional investors of Invesco Biotechnology & Genome ETF include HighTower Advisors LLC (9.60%), Cetera Investment Advisers (1.00%), Gerber Kawasaki Wealth & Investment Management (0.69%) and YHB Investment Advisors Inc. (0.51%).

Shares of PBE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Fund Details

Issuer
Invesco
Fund Name
Invesco Biotechnology & Genome ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NYSEARCA
Current Symbol
NYSEARCA:PBE
Inception Date
6/23/2005
Fund Manager
Peter Hubbard, Michael Jeanette, Pratik Doshi, Tony Seisser

Fund Focus

Asset Class
Equity
Benchmark
Dynamic Biotech & Genome Intellidex Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Constituents
30

Fund Statistics

Assets Under Management
$425.10 million
Average Daily Volume
$21.90 thousand
Discount/Premium
-0.05%

Administrator, Advisor and Custodian

Administrator
The Bank of New York Mellon Corporation
Advisor
Invesco Capital Management, LLC
Custodian
The Bank of New York Mellon Corporation
Distributor
Invesco Distributors, Inc.
Transfer Agent
The Bank of New York Mellon Corporation
Trustee
N/A
Lead Market Maker
Citadel

Options

Optionable
N/A
Short Interest
10,221 shs

Miscellaneous

Beta
0.71
Creation Unit
10,000
Creation Fee
$500.00
The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Top 10 PBE Holdings

PBE Sector Exposure

PBE Industry Exposure


This page (NYSEARCA:PBE) was last updated on 11/18/2026 by MarketBeat.com Staff.
From Our Partners